Active in North American private equity transactions that prioritize operational improvement and cash-flow restoration, he combines deal execution with hands-on operational leadership. Kenneth Donald Ouellette serves as an operating partner and investor with experience leading restructurings, driving margin expansion, executing carve-outs and overseeing portfolio integrations; background spans C-suite operating roles, board service and collaboration with sponsor-backed platforms.
Active in North American private equity transactions that prioritize operational improvement and cash-flow restoration, he combines deal execution with hands-on operational leadership. Kenneth Donald Ouellette serves as an operating partner and investor with experience leading restructurings, driving margin expansion, executing carve-outs and overseeing portfolio integrations; background spans C-suite operating roles, board service and collaboration with sponsor-backed platforms.
Specializes in North American private equity investments that emphasize operational turnarounds, cash‑flow restoration and margin expansion. Prefers control or influential minority stakes in underperforming industrial and services businesses where hands‑on governance, C‑suite interventions and carve‑out execution unlock value. Employs a 3–7 year value‑creation horizon focused on EBITDA improvement, deleveraging and disciplined capex, with conservative leverage, tight covenant oversight and prioritized cash generation. Operates as an operator‑investor, combining deal execution with rapid operational fixes and portfolio integration.
Specializes in North American private equity investments that emphasize operational turnarounds, cash‑flow restoration and margin expansion. Prefers control or influential minority stakes in underperforming industrial and services businesses where hands‑on governance, C‑suite interventions and carve‑out execution unlock value. Employs a 3–7 year value‑creation horizon focused on EBITDA improvement, deleveraging and disciplined capex, with conservative leverage, tight covenant oversight and prioritized cash generation. Operates as an operator‑investor, combining deal execution with rapid operational fixes and portfolio integration.
| Trades 439 | Longs Won 317/439 72% | Profit Factor 13.02 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $547,719.5 |
| Average Win $164,784.58 | Best Trade (Aug 17) $7.3M | Sharpe Ratio -9.79 |
| Average Loss -$32,893.15 | Worst Trade (Aug 03) -$1.42M | Z-Score 8.38 (100%) |
| Commissions $0 | Avg. Trade Length 11m | Expectancy $109,849.08 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,025 | 4,523 | 4,020 | 3,518 | 3,015 | 2,513 | 2,010 | 1,508 | 1,005 | 503 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 57,540 | $14.39M | $17.77M | - | $3.38M | 23.52% | -7.354% |
ABBV AbbVie Inc. | 10,348 | $1.85M | $2.6M | - | $748,635.7 | 40.51% | -2.513% |
ABT Abbott Laboratories | 2,424 | $276,532.32 | $256,216.8 | - | -$20,315.52 | -7.35% | +0.085% |
ALB Albemarle Corporation | 2,173 | $307,425.25 | $255,631.72 | - | -$51,793.53 | -16.85% | -0.102% |
AMAT Applied Materials, Inc. | 1,618 | $269,661.15 | $821,410.08 | - | $551,748.93 | 204.61% | +1.176% |
ASML ASML Holding N.V. New York Registry Shares | 101 | $201,037 | $164,529 | - | -$36,508 | -18.16% | -1.359% |
AVGO Broadcom Inc. | 15,925 | $3.69M | $6.2M | - | $2.51M | 67.91% | +0.371% |
AXP American Express Company | 902 | $249,582.07 | $303,297.5 | - | $53,715.43 | 21.52% | -0.376% |
AZN AstraZeneca PLC American Depositary Shares | 34,716 | $6.85M | $5.89M | - | -$956,869.16 | -13.98% | -0.992% |
BABA Alibaba Group Holding Limited SP ADR | 4,755 | $819,324.28 | $581,298.75 | - | -$238,025.53 | -29.05% | +5.098% |
BAC Bank of America Corporation | 35,087 | $1.55M | $2.17M | - | $627,285.6 | 40.57% | +0.356% |
BRK-A Berkshire Hathaway Inc. | 1 | $680,920 | $766,600 | - | $85,680 | 12.58% | +0.21% |
BRK-B Berkshire Hathaway Inc. | 4,156 | $1.92M | $2.13M | - | $207,324.25 | 10.81% | +0.365% |
BTI British American Tobacco p.l.c. ADR | 69,776 | $3.45M | $4.23M | - | $783,938.76 | 22.74% | -1.686% |
BX Blackstone Inc. | 16,680 | $2.87M | $2.13M | - | -$742,772.91 | -25.85% | -0.25% |
CAT Caterpillar Inc. | 3,288 | $1.19M | $2.68M | - | $1.49M | 124.37% | +0.701% |
CB Chubb Limited | 11,618 | $3.21M | $4.07M | - | $861,119.88 | 26.8% | +0.151% |
CGCB Capital Group Core Bond ETF | 9,766 | $251,953.9 | $251,474.5 | - | -$479.4 | -0.19% | -0.656% |
CGDV Capital Group Dividend Value ETF | 52,470 | $1.85M | $2.6M | - | $744,765.86 | 40.16% | +0.63% |
CGXU Capital Group International Focus Equity ETF | 15,525 | $399,951.14 | $519,621.75 | - | $119,670.61 | 29.92% | -0.535% |